Osteoporesis Drugs May Reduce Risk of Breast Cancer

logo1267406_md

A new study reported in the British Journal of Cancer on March 5, 2010 concluded that women who take some types of bone building drugs to prevent osteoporosis may be at a lower risk of developing breast cancer.
The study included almost 6,000 Wisconsin women betweeen the ages of 20 and 69. Half had been diagnosed with invasive breast cancer and half had not (for comparison). Women were interviewed about their bone health-their history of whether they had been diagnosed with osteoporosis, biophosphonate use and fractures. Data also included information on breast cancer risk factors such as first-degree family history of the disease, age at first birth, postmenopausal hormone use and body mass index. Results showed that women who used bisphosphonate drugs, such as Fosamax, Boniva and Zomita, for more than two years were almost 40% less likely to develop breast cancer than those who did not. This protection was not afforded women who were obese.

One Response to “Osteoporesis Drugs May Reduce Risk of Breast Cancer”

  1. […] This post was mentioned on Twitter by Sally Siegfried , Yancey @YanceyG. Yancey @YanceyG said: Osteoporesis Drugs May Reduce Risk of Breast Cancer � Holistic …: A new study reported in the British Journal of… http://bit.ly/9YNUnW […]